Myocardialis infarctus utáni szekunder prevenció.

Translated title of the contribution: Secondary prevention after myocardial infarction

Research output: Contribution to journalReview article

Abstract

The management of acute myocardial infarction has been revolutionized in the past decade. Advances in pharmacological and mechanical reperfusion therapy have improved the survival of patients who experience myocardial infarction. Although revascularisation techniques have been shown to reduce infarct size and in-hospital mortality, patients recovering from myocardial infarction are still at increased risk for reinfarction, congestive heart failure, and sudden death. Despite impressive technological advances, lifestyle modification and pharmacological interventions remain the key components of secondary prevention after myocardial infarction. Although the concept of secondary prevention of reinfarction and death has been investigated vigorously for several decades, preventive therapy has been seriously underused by physicians. The aim of this paper is to provide a comprehensive, evidence-based overview of secondary prevention postmyocardial infarction clinical trials, in the hope of improving the utilization of effective therapies in patients with coronary heart disease.

Original languageHungarian
Pages (from-to)2117-2128
Number of pages12
JournalOrvosi hetilap
Volume143
Issue number37
Publication statusPublished - Sep 15 2002

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this